Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 601-147-9 | CAS number: 111988-49-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 Oct - 10 Nov 1995
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
- Reference Type:
- other: Amendment
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted 1992
- Deviations:
- yes
- Remarks:
- justification of choice of vehicle not provided, no justification for top dose intradermal induction, a higher number of animals is recommended
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A non-LLNA test is available that was performed prior to the current data requirements, stipulated in Regulation (EC) No 1907/2006. In accordance with the same Regulation, the data was included to avoid unnecessary testing.
Test material
- Reference substance name:
- 3-(2-chlor-5-pyridyl-methyl)-cyanimino-1,3-thiazolidin
- EC Number:
- 601-147-9
- Cas Number:
- 111988-49-9
- Molecular formula:
- C10H9ClN4S
- IUPAC Name:
- 3-(2-chlor-5-pyridyl-methyl)-cyanimino-1,3-thiazolidin
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Remarks:
- Hsd Poc:DH, SPF-bred
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Marian Winkelmann GmbH Laboratory Animal Breeders, Borchen, Germany
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 5 - 6 weeks
- Weight at study initiation: 351 - 366 g
- Housing: in type IV Makrolon® cages in groups (5 animals per cage during acclimatisation and 2 - 3 animals per cage during the study) with low-dust wood shavings (Ssniff Spezialdiäten GmbH, Soest, Germany)
- Diet: "Altromin®3020 - Maintenance Diet for Guinea Pigs (Altromin, Lage, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 7 days
- Indication of any skin lesions: no
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 1.5
- Humidity (%): 40 - 70
- Air changes (per hr): 12 -15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: 2% Cremophor EL®
- Concentration / amount:
- intradermal: 5.0%/0.1 mL
epicutaneous: 50%/0.5 mL - Day(s)/duration:
- intradermal: single injection on Day 1, epicutaneous: starting on Day 8, exposure for 48 h
- Adequacy of induction:
- other: not tested up to irritant concentration causing mild irritation and no justification for selected doses (the highest dose tested did not cause skin irritation)
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: 2% Cremophor EL®
- Concentration / amount:
- 25%/0.5 mL
- Day(s)/duration:
- 24 h
- Adequacy of challenge:
- other: not tested up to irritant concentration causing mild irritation and no justification for selected doses (some irritation was noted in some animals at 50%)
- No. of animals per dose:
- 10 (treatment)/5 (control)
- Details on study design:
- RANGE FINDING TESTS
A. INDUCTION EXPOSURE
For intradermal induction: One guinea pig was given intradermal injections twice, in each case, with 0.1 mL of the following test item concentrations: 0 – 5%.
The injection sites were evaluated after 24 and 48 h. After 24 and 48 h, no reactions were observed after intradermal induction of the test formulations (0 - 5%).
For topical induction: Three concentrations (12%, 25% and 50%) and the vehicle were tested on four guinea pigs. The patches moistened with 0.5 mL of the test item formulations or the vehicle were applied to each animal under occlusive conditions for 24 h. At the end of the exposure period, the remaining test item was removed with physiological saline. No later than 21 h after removing the patches the treated areas were shorn in the zone of the challenge area. The skin reactions were evaluated 24 h and 48 h after patch removal. No skin reactions were recorded both 24 h and 48 h after topical application of the test formulations (0 - 50%).
B. CHALLENGE EXPOSURE
One week prior to the challenge, the challenge concentration was determined on 5 guinea pigs which were treated in the same manner as the control animals during the inductions. Four patches each loaded with 0.5 mL test item formulations (12%, 25% and 50%) or the vehicle were applied to each animal under occlusive conditions for 24 h. At the end of the exposure period, the remaining test item was removed with physiological saline. No later than 21 h after removing the patches the treated areas were shorn in the zone of the challenge area. The skin reactions were evaluated 48 and 72 h after start of the application. At 50% challenge, three animals showed skin reactions (Grade 1) after 48 h, two of them were reversible within the following 24 h. The other concentrations did not induce any reactions (0-25%). Based on these results, the following concentrations were selected for the main study: Intradermal induction: 5%, topical induction: 50% and challenge: 25%. For details on the results, please refer to the attached background material (Attachment 1).
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections):
Injection 1: a 1:1 mixture (v/v) Freund's Complete Adjuvant (FCA)/sterile physicological saline solution
Injection 2: 5% test substance in 2% Cremophor EL®
Injection 3: 5% test substance in a 1:1 mixture of (v/v) FCA/2% Cremophor EL®
Epicutaneous: 50% test substance in 2% Cremophor EL®
- Control group:
Injection 1: a 1:1 mixture (v/v) Freund's Complete Adjuvant (FCA)/sterile physicological saline solution
Injection 2: 2% Cremophor EL®
Injection 3: 2% Cremophor EL® in a 1:1 mixture of (v/v) FCA/2% Cremophor EL®
Epicutaneous: 2% Cremophor EL®
- pre-treatment: One day before epicutaneous treatment, a 10% preparation of sodium lauryl sulfate in vaseline was applied to the skin
- Site: dorsal region (intradermal + epicutaneous)
- Frequency of applications: once
- Duration: intradermal induction was performed on Day 1, topical induction was performed on Day 8-10
- Concentrations: intradermal 5%, epicutaneous 50%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: three weeks after the intradermal induction
- Exposure period: 24 h
- Test groups: test substance and vehicle only
- Control group: test substance and vehicle only
- Site: left flank (test substance caudal, vehicle cranial)
- Concentrations: 25%
- Evaluation (hr after challenge): 24 h and 48 h after patch removal
OTHER:
The animals were observed for clinical signs at least once daily throughout the entire study period. Body weights were recorded on Day 1 before the first induction and at the end of the study. - Challenge controls:
- The control group is actually a challenge control.
- Positive control substance(s):
- yes
- Remarks:
- The GPMT was checked for reliability in a separate study with 10 male guinea pigs using 2-mercaptobenzothiazole in 2% Cremophor EL®. The following substance concentrations were used: Intradermal induction: 2.5%, topical induction: 40%, challenge: 40%.
Results and discussion
- Positive control results:
- The following concentrations were used in the positive control 2-mercaptobenzothiazole reliability test:
intradermal induction: 2.5%
topical induction: 40%
challenge: 40%
48 h after the challenge, 55% of the test item animals and 0% of the control animals exhibited dermal reactions in the challenge treatment and after 72 h 44% of the test item animals showed clear dermal reactions. There was no reddening of the skin to be observed in control group animals. Summarized results can be found in Attachment 3.
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 5% (intradermal) 50% (epicutaneous), challenge: 25% (epicutaneous)
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- skin irritation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 5% (intradermal) 50% (epicutaneous), challenge: 25% (epicutaneous)
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Clinical observations:
- skin irritation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0% (intradermal) 0% (epicutaneous), challenge: 25% (epicutaneous)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0% (intradermal) 0% (epicutaneous), challenge: 25% (epicutaneous)
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 2.5% (intradermal) 40% (epicutaneous), challenge: 40% (epicutaneous)
- No. with + reactions:
- 5
- Total no. in group:
- 9
- Clinical observations:
- skin irritation, 1 animal died on Day 4 and was not used for evaluation. On Day 6 and 7, 1 animal showed lacrimation and turbidity of the right eye, turbidity of the right eye continued until the end of the study
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 2.5% (intradermal) 40% (epicutaneous), challenge: 40% (epicutaneous)
- No. with + reactions:
- 4
- Total no. in group:
- 9
- Clinical observations:
- skin irritation, 1 animal died on Day 4 and was not used for evaluation. On Day 6 and 7, 1 animal showed lacrimation and turbidity of the right eye, turbidity of the right eye continued until the end of the study
Any other information on results incl. tables
The appearance and behaviour of the animals in the test item group were
not significantly different from the control group.
At the end of the study, the mean body weight of the treatment group
animals was in the same range as that of the control group animals.
Summarized results can be found in Attachment 2.
The following results were obtained for further groups:
test chemical: 5% (intradermal), 50% (epicutaneous), challenge: 0% (epicutaneous): 0/10 animals showed reactions) after both 24 and 48 h
Vehicle: 0% (intradermal), 0% (epicutaneous), challenge: 0% (epicutaneous): 0/5 animals showed reactions) after both 24 and 48 h
Positive control: 2.5% (intradermal), 40% (epicutaneous), challenge: 0% (epicutaneous): 0/9 animals showed reactions) after both 24 and 48 h
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 12 72/2008.
- Conclusions:
- The study is in accordance with OECD guideline 406, was conducted under GLP and is considered valid and reliable. The challenge treatment with the 25% test substance formulation led to skin reactions
(grade 1) in 1/10 (10%) of the test group animals. There was no skin reaction in the control group animals. Under the conditions chosen, the test substance did not exhibit a skin sensitisation potential. According to criteria of the CLP Regulation (EU) No. 1272/2008, no classification of the test item in regards to skin sensitisation is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.